130 related articles for article (PubMed ID: 18983502)
1. Acute endothelial tissue plasminogen activator release in pregnancy.
Robb AO; Mills NL; Din JN; Cameron S; Ludlam CA; Newby DE; Denison FC
J Thromb Haemost; 2009 Jan; 7(1):138-42. PubMed ID: 18983502
[TBL] [Abstract][Full Text] [Related]
2. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.
Labinjoh C; Newby DE; Dawson P; Johnston NR; Ludlam CA; Boon NA; Webb DJ
Cardiovasc Res; 2000 Sep; 47(4):707-14. PubMed ID: 10974219
[TBL] [Abstract][Full Text] [Related]
4. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
5. Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men.
Chia S; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2003 Jan; 41(2):333-9. PubMed ID: 12535831
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
7. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man.
Newby DE; Wright RA; Dawson P; Ludlam CA; Boon NA; Fox KA; Webb DJ
Cardiovasc Res; 1998 May; 38(2):485-92. PubMed ID: 9709410
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man.
Pellegrini MP; Newby DE; Maxwell S; Webb DJ
Cardiovasc Res; 2001 Nov; 52(2):321-7. PubMed ID: 11684081
[TBL] [Abstract][Full Text] [Related]
9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition.
Labinjoh C; Newby DE; Pellegrini MP; Johnston NR; Boon NA; Webb DJ
J Am Coll Cardiol; 2001 Nov; 38(5):1402-8. PubMed ID: 11691515
[TBL] [Abstract][Full Text] [Related]
11. Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
Witherow FN; Dawson P; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2002 Sep; 40(5):961-6. PubMed ID: 12225723
[TBL] [Abstract][Full Text] [Related]
12. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.
Li Y; Chen H; Tan J; Wang X; Liang H; Sun X
Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Newby DE; Wright RA; Labinjoh C; Ludlam CA; Fox KA; Boon NA; Webb DJ
Circulation; 1999 Mar; 99(11):1411-5. PubMed ID: 10086962
[TBL] [Abstract][Full Text] [Related]
14. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
15. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension.
Jern S; Wall U; Bergbrant A; Selin-Sjögren L; Jern C
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3376-83. PubMed ID: 9437182
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
[TBL] [Abstract][Full Text] [Related]
20. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]